Current Research: Retatrutide is the first triple agonist peptide targeting the Glucagon, GLP-1, and GIP receptors (3G), with EC50 values of 5.79 nM, 0.0643 nM, and 0.775 nM, respectively [1]. It is currently in the final stage of clinical trials, with many benefits that include maintaining healthy muscles.

Each capsule formulary has the added benefit of Sodium salcaprozate (SNAC) 3mg to enhance absorption. Please do not add this item to the shopping cart, as it is contract-manufactured upon order. Contact us for minimum quantity, bulk pricing, or packaging inquiries. MQTY runs from 140,000 to 1.64MM counts.